Insurers selling coverage in North Carolina, Pennsylvania and New York, among other states, said they won’t cover Leqembi with insurance offered on the individual market and through employers because they still see the $26,000-a-year drug as experimental.
FILE - This image provided by Eisai in January 2023 shows vials and packaging for their medication, Leqembi. Several health plans in the U.S. will not cover the recently approved Alzheimer’s drug for certain customers, exposing those patients to thousands of dollars in potential costs. Their decision stands in contrast to Medicare.
But people under 65 — even, rarely, as young as their 30s — also can get diagnosed. They are more likely to have commercial coverage. “That re-evaluation made it clear to us that the existing evidence does not allow for conclusions to be drawn about the safety and effectiveness of Leqembi,” said Dr. Heidi Syropoulos, a medical director with the insurer.
For commercial coverage, insurers often pay for treatments that have full FDA approval. But that is not guaranteed.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
‘Tallest,’ ‘fastest’ giga roller coaster in North America reopens after eagle-eyed guest helps avert disasterCarowinds straddles the border of North Carolina and South Carolina, but Fury 325 is on the park’s North Carolina side.
Weiterlesen »
Kurt Vile, Nikki Lane, and Skynyrd's Ex-Drummer Help Asheville Get into the Festival GameREVIEW: The inaugural AVLfest was a welcomed bohemian addition to the festival family. From Kurt Vile to Nikki Lane, these are the best things we saw in Asheville ⬇️
Weiterlesen »
Teen says she was sent home from Chick-fil-A job for having an ‘unnatural’ hair color: BlondA teenager says her supervisor at Chick-fil-A sent her home for having an “unnatural” hair color: Blond.
Weiterlesen »
Insurers won’t cover new Alzheimer’s treatment for some customersLeqembi is the first medicine that’s been convincingly shown to slow the cognitive decline caused by Alzheimer’s disease, though only modestly.
Weiterlesen »